DRGTX vs. RAGHX

In the year-to-date period, DRGTX achieves a -7.82% return, which is significantly lower than RAGHX's -6.54% return. Over the past 10 years, DRGTX has outperformed RAGHX with an annualized return of 17.12%, while RAGHX has yielded a comparatively lower -3.38% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

DRGTX has a 1.16% expense ratio, which is lower than RAGHX's 1.37% expense ratio.

This table presents a comparison of risk-adjusted performance metrics for Virtus Technology Fund (DRGTX) and Virtus Health Sciences Fund (RAGHX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current DRGTX Sharpe Ratio is 0.33, which is higher than the RAGHX Sharpe Ratio of -0.83. The chart below compares the historical Sharpe Ratios of DRGTX and RAGHX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither DRGTX nor RAGHX has paid dividends to shareholders.

The maximum DRGTX drawdown since its inception was -83.33%, which is greater than RAGHX's maximum drawdown of -40.80%. Use the drawdown chart below to compare losses from any high point for DRGTX and RAGHX. For additional features, visit the drawdowns tool.